Building Singapore's biological ageing index for healthier, longer lives.
BioAge Connect is an independent public-benefit nexus advancing SG-BAI, clinical validation, and cfDNA biomarkers so people and health systems can act earlier against morbidity and cognitive decline.
Problem
Chronological age misses biological variation.
Approach
Validate methylation clocks, phenotypic clocks, and cfDNA for Singapore.
Outcome
Earlier prevention, intervention tracking, and population-scale healthy ageing insight.
Designed for healthy ageing at every level
The landing page now reflects the program itself: rigorous biomarker science, clinical validation, longitudinal monitoring, and public-health relevance for Singapore.
Singapore Biological Ageing Index
Develop an Asian-calibrated biological ageing index grounded in DNA methylation, phenotypic clocks, and clinically relevant biomarkers.
Earlier morbidity prediction
Assess whether SG-BAI improves prediction of near- and medium-term morbidity risk beyond chronological age and standard clinical factors.
Pre-clinical dementia signals
Validate plasma cfDNA as a scalable marker for early neurodegenerative risk before clinical symptoms become obvious.
Clinical implementation
Translate promising biomarkers into standardized assays, reproducible workflows, and operationally feasible care pathways.
Intervention monitoring
Track biological age changes over time to support healthier lifestyle decisions and evaluate therapeutic responses.
Population-level impact
Provide a national indicator for healthy ageing that can guide prevention strategy, investment, and long-term care planning.
Healthy longevity needs a better signal than age in years.
Singapore is entering an ageing society, but people do not age at the same biological pace. BioAge Connect is being built to close that measurement gap with a national biological ageing index that can detect risk earlier, guide interventions, and support healthier years of life.
Primary aim
Predict morbidity earlier
Core measure
Singapore Biological Ageing Index
Validation path
DNA methylation, phenotypic clocks, cfDNA
Population value
Prevention, monitoring, national insight
National impact
A platform for prevention, monitoring, and healthier ageing across Singapore.
BioAge Connect is designed to help individuals, clinicians, researchers, and policymakers understand how ageing is changing over time, and where earlier action can reduce disease burden and extend healthspan.
1
National healthy-longevity mission
2
Research questions driving the program
3
Signal families integrated into SG-BAI validation
4
Tracking for prevention and intervention monitoring
BioAge Connect will recalibrate and validate biological ageing measures using Singapore cohorts so biological age can improve morbidity prediction beyond chronological age and standard clinical factors.
The platform will evaluate plasma cfDNA as a robust biomarker for early dementia risk, moving from promising proof-of-concept work into standardized, clinically useful workflows.
This initiative pairs assay validation with operational design so clinicians, researchers, and public-health teams can use longitudinal biological age tracking at population scale.
A translational program from biomarker science to real-world prevention.
The project combines clinical validation, laboratory standardization, bioinformatics, and implementation planning so biological ageing signals can move beyond the research setting into healthcare and population-level monitoring.
Building the evidence base for healthier ageing decisions.
BioAge Connect will connect biomarker science, clinical validation, and digital longitudinal tracking so Singapore can move from reactive care toward earlier prevention and more precise intervention.